Methylene blue-induced Heinz body hemolytic anemia (1994)

Peer-Reviewed Study · Sills MR, Zinkham WH · March 1994

Sills MR et al., 1994-03: Case series of two infants who developed Heinz-body haemolytic anaemia from methylene blue – one exposed as an intraoperative marker, one treated for type II glutaric acidemia – with phototherapy and transfusion, plus a literature review of methylene blue toxicity.

Two infants, one a neonate with trisomy 21 exposed to methylene blue as an intraoperative diagnostic marker and the other a neonate treated with methylene blue for type II glutaric acidemia.

Sills MR et al., 1994-03: Case series of two infants who developed Heinz-body haemolytic anaemia from methylene blue – one exposed as an intraoperative marker, one treated for type II glutaric acidemia – with phototherapy and transfusion, plus a literature review of methylene blue toxicity. C4 neonatal haemolysis. Dose/route: intraoperative diagnostic marker in one; therapeutic dosing for glutaric acidemia type II in the other (doses not in abstract). Funder/conflicts not stated. Comparator: none. Establishes that haemolysis occurs in neonates without documented G6PD deficiency. Study type: uncontrolled series.